Regulation of integrin affinity on cell surfaces

EMBO Journal

Volumn 30, Issue 23, 2011, Pages 4712-4727

  Schürpf, Thomas ^a   Springer, Timothy A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CD11a CD18; ICAM 1; Lymphocyte functionassociated antigen 1 (LFA 1); Metal ion dependent adhesion site (MIDAS); Stromal cell derived factor (SDF)

Indexed keywords

CELL ADHESION MOLECULE; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL ADHESION; CELL SURFACE; PRIORITY JOURNAL; T LYMPHOCYTE;

CELL ADHESION; CHEMOKINE CXCL12; HEK293 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; K562 CELLS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN CONFORMATION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 82455189778     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.333     Document Type: Article

References (75)

1. Alonso JL, Essafi M, Xiong JP, Stehle T, Arnaout MA (2002) Does the integrin aA domain act as a ligand for its bA domain? Curr Biol 12: R340-R342
2. Aricescu AR, Lu W, Jones EY (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62(Part 10): 1243-1250
3. Beglova N, Blacklow SC, Takagi J, Springer TA (2002) Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol 9: 282-287
4. Bolomini-Vittori M, Montresor A, Giagulli C, Staunton D, Rossi B, Martinello M, Constantin G, Laudanna C (2009) Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol 10: 185-194
5. Chen X, Xie C, Nishida N, Li Z, Walz T, Springer TA (2010) Requirement of open headpiece conformation for activation of leukocyte integrin aXb2. Proc Natl Acad Sci USA 107: 14727-14732
6. Constantin G, Majeed M, Giagulli C, Piccib L, Kim JY, Butcher EC, Laudanna C (2000) Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13: 759-769
7. Dransfield I, Cabañas C, Craig A, Hogg N (1992) Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 116: 219-226
8. 2+ binding epitope on leukocyte integrin alpha subunits. EMBO J 8: 3759-3765
9. Drbal K, Angelisova P, Cerny J, Hilgert I, Horejsi V (2001) A novel anti-CD18mAb recognizes an activation-related epitope and induces a high-affinity conformation in leukocyte integrins. Immunobiology 203: 687-698
10. Dustin ML, Bromley SK, Zhengyan K, Peterson DA, Unanue ER (1997) Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 94: 3909-3913
11. Dustin ML, Springer TA (1989) T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341: 619-624
12. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC (2000) Structural basis of collagen recognition by integrin a2b1. Cell 101: 47-56
13. Feigelson SW, Pasvolsky R, Cemerski S, Shulman Z, Grabovsky V, Ilani T, Sagiv A, Lemaitre F, Laudanna C, Shaw AS, Alon R (2010) Occupancy of lymphocyte LFA-1 by surface-immobilized ICAM-1 is critical for TCR- but not for chemokine-triggered LFA-1 conversion to an open headpiece high-affinity state. J Immunol 185: 7394-7404
14. Gadek TR, Burdick DJ, McDowell RS, Stanley MS, Marsters Jr JC, Paris KJ, Oare DA, Reynolds ME, Ladner C, Zioncheck KA, Lee WP, Gribling P, Dennis MS, Skelton NJ, Tumas DB, Clark KR, Keating SM, Beresini MH, Tilley JW, Presta LG et al (2002) Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 295: 1086-1089
15. Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T (2009) Regulation of integrin activity and signalling. Biochem Biophys Acta 1790: 431-444
16. Ganpule G, Knorr R, Miller JM, Carron CP, Dustin ML (1997) Low affinity of cell surface lymphocyte function-associated antigen-1 (LFA-1) generates selectivity for cell-cell interactions. J Immunol 159: 2685-2692
17. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML (1999) The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227
18. Gross CC, Brzostowski JA, Liu D, Long EO (2010) Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization. J Immunol 185: 2918-2926
19. Hibbs ML, Xu H, Stacker SA, Springer TA (1991) Regulation of adhesion to ICAM-1 by the cytoplasmic domain of LFA-1 integrin b subunit. Science 251: 1611-1613
20. Humphries MJ (2000) Integrin structure. Biochem Soc Trans 28: 311-339
21. Huth JR, Olejniczak ET, Mendoza R, Liang H, Harris EA, Lupher Jr ML, Wilson AE, Fesik SW, Staunton DE (2000) NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci USA 97: 5231-5236
22. Jin M, Song G, Kim Y-S, Astrof N, Shimaoka M, Wittrup D, Springer TA (2006) Directed evolution to probe protein allostery and integrin I domains of 200 000-fold higher affinity. Proc Natl Acad USA 103: 5758-5763
23. Kaizuka Y, Douglass AD, Varma R, Dustin ML, Vale RD (2007) Mechanisms for segregating T cell receptor and adhesion molecules during immunological synapse formation in Jurkat T cells. Proc Natl Acad USA 104: 20296-20301
24. Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U (1999) Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a Idomain. J Mol Biol 292: 1-9
25. Kim M, Carman CV, Springer TA (2003) Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301: 1720-1725
26. Kim M, Carman CV, Yang W, Salas A, Springer TA (2004) The primacy of affinity over clustering in regulation of adhesiveness of the integrin aLb2. J Cell Biol 167: 1241-1253
27. Kucik DF, Dustin ML, Miller JM, Brown EJ (1996) Adhesionactivating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 97: 2139-2144
28. Kung PC, Goldstein G, Reinherz EL, Schlossman SF (1979) Monoclonal antibodies defining distinctive human T cell surface antigens. Science NY 206: 347-349
29. Last-Barney K, Davidson W, Cardozo M, Frye LL, Grygon CA, Hopkins JL, Jeanfavre DD, Pav S, Qian C, Stevenson JM, Tong L, Zindell R, Kelly TA (2001) Binding site elucidation of hydantoin- based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein-protein interaction. J Am Chem Soc 123: 5643-5650
30. Lau TL, Kim C, Ginsberg MH, Ulmer TS (2009) The structure of the integrin aIIbb3 transmembrane complex explains integrin transmembrane signalling. EMBO J 9: 1351-1361
31. Lee J-O, Rieu P, Arnaout MA, Liddington R (1995) Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/ CD18). Cell 80: 631-638
32. Li YF, Tang RH, Puan KJ, Law SK, Tan SM (2007) The cytosolic protein talin induces an intermediate affinity integrin aLb2. J Biol Chem 282: 24310-24319
33. Lollo BA, Chan KW, Hanson EM, Moy VT, Brian AA (1993) Direct evidence for two affinity states for lymphocyte functionassociated antigen 1 on activated T cells. J Biol Chem 268: 21693-21700
34. Lu C, Ferzly M, Takagi J, Springer TA (2001a) Epitope mapping of antibodies to the C-terminal region of the integrin β2 subunit reveals regions that become exposed upon receptor activation. J Immunol 166: 5629-5637
35. 2 sufficient for strong adhesive function when locked in the open conformation with a disulfide. Proc Natl Acad Sci USA 98: 2387-2392
36. Lu C, Shimaoka M, Salas A, Springer TA (2004) The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1. J Immunol 173: 3972-3978
37. 2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA 98: 2393-2398
38. Lu C, Springer TA (1997) The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1 (LFA-1). J Immunol 159: 268-278
39. Lub M, van Vliet SJ, Oomen SP, Pieters RA, Robinson M, Figdor CG, van Kooyk Y (1997) Cytoplasmic tails of beta1, beta2, and beta7 integrins differentially regulate LFA-1 function in K562 cells. Mol Biol Cell 8: 719-728
40. Luo B-H, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25: 619-647
41. Mempel TR, Henrickson SE, Von Andrian UH (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427: 154-159
42. Moser M, Legate KR, Zent R, Fassler R (2009) The tail of integrins, Talin and Kindlins. Science 234: 895-899
43. Nishida N, Xie C, Shimaoka M, Cheng Y, Walz T, Springer TA (2006) Activation of leukocyte b2 integrins by conversion from bent to extended conformations. Immunity 25: 583-594
44. Petruzzelli L, Maduzia L, Springer TA (1995) Activation of LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18. J Immunol 155: 854-866
45. Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline- inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99: 13419-13424
46. Robinson MK, Andrew D, Rosen H, Brown D, Ortlepp S, Stephens P, Butcher EC (1992) Antibody against the Leu-cam b-chain (CD18) promotes both LFA-1-and CR3-dependent adhesion events. J Immunol 148: 1080-1085
47. Salas A, Shimaoka M, Kogan AN, Harwood C, von Andrian UH, Springer TA (2004) Rolling adhesion through an extended conformation of integrin aLb2 and relation to a I and b I-like domain interaction. Immunity 20: 393-406
48. Sanchez-Madrid F, Krensky AM,Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA (1982) Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA- 2, and LFA-3. Proc Natl Acad Sci USA 79: 7489-7493
49. Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W, Robinson MK, Staunton DE, von Andrian UH, Alon R (2005) Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 6: 497-506
50. Shi M, Foo SY, Tan SM, Mitchell EP, Law SK, Lescar J (2007) A structural hypothesis for the transition between bent and extended conformations of the leukocyte b2 integrins. J Biol Chem 282: 30198-30206
51. Shi M, Sundramurthy K, Liu B, Tan SM, Law SK, Lescar J (2005) The crystal structure of the plexin-semaphorin-integrin domain/hybrid domain/I-EGF1 segment from the human integrin b2 subunit at 1.8-A resolution. J Biol Chem 280: 30586-30593
52. Shimaoka M, Kim M, Cohen EH, Yang W, Astrof N, Peer D, Salas A, Ferrand A, Springer TA (2006) AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity upregulation in lymphocytes. Proc Natl Acad Sci USA 103: 13991-13996
53. Shimaoka M, Lu C, Palframan R, von Andrian UH, Takagi J, Springer TA (2001) Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin aL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci USA 98: 6009-6014
54. Shimaoka M, Salas A, Yang W, Weitz-Schmidt G, Springer TA (2003a) Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in another. Immunity 19: 391-402
55. Shimaoka M, Springer TA (2003) Therapeutic antagonists and the conformational regulation of integrin structure and function. Nat Rev Drug Disc 2: 703-716
56. Shimaoka M, Xiao T, Liu J-H, Yang Y, Dong Y, Jun C-D, McCormack A, Zhang R, Joachimiak A, Takagi J, Wang J-h, Springer TA (2003b) Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112: 99-111
57. Shulman Z, Shinder V, Klein E, Grabovsky V, Yeger O, Geron E, Montresor A, Bolomini-Vittori M, Feigelson SW, Kirchhausen T, Laudanna C, Shakhar G, Alon R (2009) Lymphocyte crawling and transendothelial migration require chemokine triggering of highaffinity LFA-1 integrin. Immunity 30: 384-396
58. Song G, Lazar GA, Kortemme T, Shimaoka M, Desjarlais JR, Baker D, Springer TA (2006) Rational design of ICAM-1 variants for antagonizing integrin LFA-1-dependent adhesion. J Biol Chem 281: 5042-5049
59. Springer TA, Galfre G, Secher DS, Milstein C (1979) Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9: 301-306
60. Stanley P, Smith A, McDowall A, Nicol A, Zicha D, Hogg N (2008) Intermediate-affinity LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the T cell. EMBO J 27: 62-75
61. Stewart MP, Cabanas C, Hogg N (1996) T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. J Immunol 156: 1810-1817
62. Takagi J, Petre BM, Walz T, Springer TA (2002) Global conformational rearrangements in integrin extracellular domains in outside- in and inside-out signaling. Cell 110: 599-611
63. Tang RH, Tng E, Law SK, Tan SM (2005) Epitope mapping of monoclonal antibody to integrin aLb2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding. J Biol Chem 280: 29208-29216
64. Tang XY, Li YF, Tan SM (2008) Intercellular adhesion molecule-3 binding of integrin aLb2 requires both extension and opening of the integrin headpiece. J Immunol 180: 4793-4804
65. van Kooyk Y, van Vliet SJ, Figdor CG (1999) The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem 274: 26869-26877
66. Wegener KL, Partridge AW, Han J, Pickford AR, Liddington RC, Ginsberg MH, Campbell ID (2007) Structural basis of integrin activation by talin. Cell 128: 171-182
67. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7: 687-692
68. Xiao T, Takagi J, Wang J-h, Coller BS, Springer TA (2004) Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics. Nature 432: 59-67
69. Xie C, Zhu J, Chen X, Mi L, Nishida N, Springer TA (2010) Structure of an integrin with an a I domain, complement receptor type 4. EMBO J 29: 666-679
70. 3. Science 294: 339-345
71. Yang W, Carman CV, Kim M, Salas A, Shimaoka M, Springer TA (2006) A small molecule agonist of an integrin, aLb2. J Biol Chem 281: 37904-37912
72. Yang W, Shimaoka M, Salas A, Takagi J, Springer TA (2004) Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci USA 101: 2906-2911
73. Ye F, Hu G, Taylor D, Ratnikov B, Bobkov AA, McLean MA, Sligar SG, Taylor KA, Ginsberg MH (2010) Recreation of the terminal events in physiological integrin activation. J Biol Chem 188: 157-173
74. 3. Mol Cell 34: 234-249
75. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA (2008) Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 32: 849-861